Form 8-K - Current report:
SEC Accession No. 0001654954-20-005473
Filing Date
2020-05-14
Accepted
2020-05-14 16:04:08
Documents
2
Period of Report
2020-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 30468
2 PRESS RELEASE DATED MAY 14, 2020 ndra_ex991.htm EX-99.1 192309
  Complete submission text file 0001654954-20-005473.txt   224013
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 20877683
SIC: 3845 Electromedical & Electrotherapeutic Apparatus